Bruckert E - Search Results

1

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T; LIDO Study Group. Ratziu V, et al. Among authors: bruckert e. Gastroenterology. 2005 Jun;128(7):1898-906. doi: 10.1053/j.gastro.2005.03.084. Gastroenterology. 2005. PMID: 15940625 Clinical Trial.

2

Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.

Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B. Bastard JP, et al. Among authors: bruckert e. J Clin Endocrinol Metab. 2002 May;87(5):2084-9. doi: 10.1210/jcem.87.5.8450. J Clin Endocrinol Metab. 2002. PMID: 11994345

3

Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk.

Beaudeux JL, Burc L, Imbert-Bismut F, Giral P, Bernard M, Bruckert E, Chapman MJ. Beaudeux JL, et al. Among authors: bruckert e. Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):e7-10. doi: 10.1161/01.atv.0000047448.76485.b8. Arterioscler Thromb Vasc Biol. 2003. PMID: 12524241

4

Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.

Bruckert E, Giral P, Tellier P. Bruckert E, et al. Circulation. 2003 Jul 1;107(25):3124-8. doi: 10.1161/01.CIR.0000072345.98581.24. Circulation. 2003. PMID: 12835406 Review. No abstract available.

5

Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.

Beaudeux JL, Giral P, Bruckert E, Bernard M, Foglietti MJ, Chapman MJ. Beaudeux JL, et al. Among authors: bruckert e. Atherosclerosis. 2003 Jul;169(1):139-46. doi: 10.1016/s0021-9150(03)00149-7. Atherosclerosis. 2003. PMID: 12860260

6

Lipoprotein lipase activity and common gene variants in severely hypertriglyceridemic patients with and without diabetes.

Chadarevian R, Foubert L, Beucler I, Kottler ML, Raisonnier A, Ajlouni A, Giral P, Turpin G, Bruckert E. Chadarevian R, et al. Among authors: bruckert e. Horm Res. 2003;60(2):61-7. doi: 10.1159/000071872. Horm Res. 2003. PMID: 12876415

7

Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.

Bruckert E, Lièvre M, Giral P, Crepaldi G, Masana L, Vrolix M, Leitersdorf E, Dejager S. Bruckert E, et al. Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):225-31. doi: 10.1111/j.1076-7460.2003.02000.x. Am J Geriatr Cardiol. 2003. PMID: 12888702 Clinical Trial.

8

Patients' and physicians' perceptions and experience of hypercholesterolaemia: a qualitative study.

Durack-Bown I, Giral P, d'Ivernois JF, Bazin C, Chadarevian R, Benkritly A, Bruckert E. Durack-Bown I, et al. Among authors: bruckert e. Br J Gen Pract. 2003 Nov;53(496):851-7. Br J Gen Pract. 2003. PMID: 14702904 Free PMC article.

9

Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.

Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ. Beaudeux JL, et al. Among authors: bruckert e. Clin Chem Lab Med. 2004 Feb;42(2):121-31. doi: 10.1515/CCLM.2004.024. Clin Chem Lab Med. 2004. PMID: 15061349 Review.

10

A comprehensive description of muscle symptoms associated with lipid-lowering drugs.

Franc S, Dejager S, Bruckert E, Chauvenet M, Giral P, Turpin G. Franc S, et al. Among authors: bruckert e. Cardiovasc Drugs Ther. 2003 Sep-Nov;17(5-6):459-65. doi: 10.1023/b:card.0000015861.26111.ab. Cardiovasc Drugs Ther. 2003. PMID: 15107601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters